Posaconazole is effective in preventing invasive fungal infections and is primarily used to treat candidiasis, demonstrating clinically proven efficacy and a favorable safety profile. It exerts antifungal activity by inhibiting the biosynthesis of ergosterol—an essential component for maintaining fungal cell membrane integrity, facilitating membrane-associated protein functions, and supporting cell cycle progression.